[Treatment for adult T-cell leukemia-lymphoma].
Tsukasaki
Kunihiro
K
Department of Molecular Medicine and Hematology, Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Science, Nagasaki, Japan.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D055808:Drug Discovery; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000473:pathology / Q000601:surgery* / Q000628:therapy* / Q000821:virology; D050130:Oncolytic Virotherapy; D011379:Prognosis; D015996:Survival Rate; D015215:Zidovudine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D015215:Zidovudine; D007372:Interferons